Congressman Tonko works hard to ensure that our healthcare system is strong, accessible, and efficient. The Congressman has worked to bring federal funding and support for our local hospitals and healthcare providers that bring quality, affordable care to those who need it most. Congressman Tonko works with a broad spectrum of constituents, including patients, healthcare workers, veterans, and students to address their healthcare concerns and find commonsense solutions.
Medicaid DOC Act
A bill to improve access to doctors for Medicare beneficiaries. This bill requires states that have a fee for service or a primary care case management program to provide a list of physicians who served Medicare patients in the last year.
School-Based Health Centers Reauthorization Act of 2020
A bill to reauthorize and update the School-Based Health Centers (SBHC) program through 2026. This program expands access to healthcare for students by establishing health centers in or near schools.
Health Care Workforce Protection Act
A bill to increase access to critically needed N95 respirators for frontline healthcare workers during the COVID-19 pandemic by adding NIOSH-certified respirators as a covered countermeasure under the Public Readiness and Emergency Preparedness (PREP) Act.
Fort McClellan Health Registry Act
A bill to require the creation of a health registry to track links between service at Fort McClellan and the severe life-long health problems plaguing the veterans who served there. This legislation was signed into law as part of the Honoring our PACT Act and covers veterans who served at Fort McClellan between January 1, 1935, and May 20, 1999.
Helping Experts Accelerate Rare Treatments (HEART) Act
A bill to strengthen the U.S. Food and Drug Administration review process for drugs that treat rare and ultra-rare diseases by directly involving patients, families, scientists, and doctors with expertise throughout the review process. Inspired by work with a local constituent whose daughter suffers from a rare disease, this legislation amplifies the voices of patients in the FDA review process and accelerates the deployment of promising new treatments.
